Submit :
News                      Photos                     Just In                     Debate Topic                     Latest News                    Articles                    Local News                    Blog Posts                     Pictures                    Reviews                    Recipes                    
Doctor asked to stop performing the controversial 'three-parent' baby technique by FDA
A child has DNA of the two of its parents. Yes, two, but what about three? A doctor from New York had last year shot into headlines after claiming to have helped a couple have a child with DNA from three people.

But now, the doctor has received a warning from the Food and Drug Administration (FDA) and has been asked stop performing the controversial procedure.

The doctor has been identified as John Zhang and is the founder and CEO of a fertility centre in New York known as New Hope Fertility Center. 

In the controversial procedure, what Zhang actually did was to extract chromosomes from the egg of the mother and inject them into an egg of another woman. This way, a mother with a genetic mutation could avoid passing it on to her child. But this would be possible only when the woman into whose egg the chromosomes are injected, does not carry the mutation. The mother, on whom the experiment was carried, was suffering from Leigh syndrome and did not want to pass it on to her child. 

Last year, Zhang helped a Jordanian couple have a baby boy through this technique. In 2016, Zhang applied for permission to conduct the procedure on a larger (commercial) level.

Despite the approval from FDA been pending, Zhang had been advertising this procedure widely. He even claims that the procedure would prevent the child from carrying 'maternally transmitted diseases'.

Zhang might have to face serious action as he was carrying out the procedure despite clearly being asked by the FDA not to do so within the boundaries of the United States. 

Not only was the procedure not approved by the FDA, the Congress had even barred the FDA from even reviewing such proposals.

Email Id
Verification Code
Email me on reply to my comment
Email me when other CJs comment on this article
Sign in to set your preference
merinews for RTI activists

Not finding what you are looking for? Search here.